Imperial College London
Portrait Picture

Professor Hani Gabra

Faculty of Medicine, Department of Surgery & Cancer

Emeritus Professor of Medical Oncology
 
 
 
//

Contact

 

h.gabra Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

Garry Weston CentreCancer CentreHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Herzog:2021,
author = {Herzog, T and Pignata, S and Ghamande, S and Rubio, M-J and Fujiwara, K and Vulsteke, C and Armstrong, D and Sehouli, J and Coleman, R and Gabra, H and Scambia, G and Monk, B and Arija, JA and Ushijima, K and Hanna, R and Zamagni, C and Wenham, R and Gonzalez-Martin, A and Slomovitz, B and Jia, Y and Ramsay, L and Tewari, K and Weil, S and Vergote, I},
pages = {S38--S39},
publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
title = {A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy/safety of farletuzumab in combination with carboplatin plus paclitaxel or carboplatin plus pegylated liposomal doxorubicin (PLD) in women with low CA-125 platinum-sensitive ovarian cancer},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687070800063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Herzog,T
AU  - Pignata,S
AU  - Ghamande,S
AU  - Rubio,M-J
AU  - Fujiwara,K
AU  - Vulsteke,C
AU  - Armstrong,D
AU  - Sehouli,J
AU  - Coleman,R
AU  - Gabra,H
AU  - Scambia,G
AU  - Monk,B
AU  - Arija,JA
AU  - Ushijima,K
AU  - Hanna,R
AU  - Zamagni,C
AU  - Wenham,R
AU  - Gonzalez-Martin,A
AU  - Slomovitz,B
AU  - Jia,Y
AU  - Ramsay,L
AU  - Tewari,K
AU  - Weil,S
AU  - Vergote,I
EP  - 39
PB  - ACADEMIC PRESS INC ELSEVIER SCIENCE
PY  - 2021///
SN  - 0090-8258
SP  - 38
TI  - A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy/safety of farletuzumab in combination with carboplatin plus paclitaxel or carboplatin plus pegylated liposomal doxorubicin (PLD) in women with low CA-125 platinum-sensitive ovarian cancer
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687070800063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download